Claim Missing Document
Check
Articles

Found 2 Documents
Search

Phytochemical Screening and Thin Layer Chromatography Analysis of Ethanol Extract of Bangle Rhizome (Zingiberis cassumunar Roxb.) Ananda Choirinisa Eka Putri; Perdana Priya Haresmita; Indra Yudhawan; Diyah Tri Utami; Alfian Syarifuddin
Jurnal Ilmu Kesehatan Vol 13 No 1 (2025): Jurnal Ilmu Kesehatan
Publisher : Universitas Muhammadiyah Kalimantan Timur

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Bangle rhizome (Zingiber cassumunar Roxb.) is a part of the plant that is widely used in traditional medicine because its diverse secondary metabolites have great potential in treating various diseases. The aim of this research is to identify the content of curcumin and active compounds found in bangle rhizome (Zingiber cassumunar Roxb.) qualitatively and quantitatively using Thin Layer Chromatography and UV-Vis Spectrophotometry methods. The maceration method was used to extract the bangle rhizome with 70% ethanol solvent, resulting in an extract yield of 7.92%. The results of the study from qualitative analysis using Thin Layer Chromatography (TLC) with 3 different mobile phases, namely chloroform: ethanol (95:5), chloroform: methanol: glacial acetic acid (94:5:1), and chloroform: n-hexane: methanol (1:1:0.1), indicate that the ethanol extract from the bangle rhizome positively contains polyphenolic compounds, terpenoids, and glycosides. Quantitative analysis of curcumin using UV-Vis Spectrophotometry at a wavelength of 437 nm resulted in a linear equation y = 0.026x + 0.1026 with an R² value of 0.9958 and r = 0.997898. The absorbance values from the 3 replicates of the bangle rhizome ethanol extract sample solution obtained in this study were 0.35 nm; 0.38 nm; 0.392 nm, indicating the presence of curcumin in all three replicates of the bangle rhizome ethanol extract solution. Based on the research results, it can be concluded that the ethanol extract of bangle rhizome (Zingiber cassumunar Roxb.) positively contains polyphenolic compounds, terpenoids, glycosides, and curcumin.
Pharmacist-Doctor Collaboration Gaps & Diabetes Patient Quality of Life: Case study at Hospital X in Magelang Cut Dewi Bunga; Elmiawati Latifah; Yasmine Noorindah Zulfani; Ariska Yulaikha; Bilqis Rahil Azizah; Perdana Priya Haresmita
Journal of Public Health and Pharmacy Vol. 6 No. 1: MARCH 2026
Publisher : Pusat Pengembangan Teknologi Informasi dan Jurnal Universitas Muhammadiyah Palu

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56338/jphp.v6i1.6478

Abstract

ntroduction: According to data gathered from the Medical Records Unit of Hospital (RS) X in Magelang City for the year 2022, diabetes was the most prevalent condition, with a total of 2,866 recorded cases. To enhance treatment outcomes for patients, particularly those with chronic diseases, it is essential for physicians and pharmacists to collaborate effectively. Effective communication and collaboration among healthcare professionals, including physicians and pharmacists, are crucial to ensure seamless service delivery. This study aims to examine the gaps in collaboration among healthcare professionals—particularly between pharmacists and physicians—by exploring the current implementation of collaboration, identifying the challenges faced, and recommending strategies to optimize pharmacist-physician collaboration. Strengthening this collaboration may contribute to improving the quality of life of patients with diabetes. Methods: This study employs a qualitative approach, utilizing data collection methods such as interviews and focus group discussions, structured into seven distinct stages. The participants in this study include medical professionals, pharmacists, members of the pharmacy and therapeutics committees, hospital management personnel, and patients. Data analysis was conducted using explicitation techniques with the aid of the NVivo 12 software application, resulting in the identification of four key themes. Results: Through a qualitative approach, four main themes were identified. The first theme is the role of the Pharmacy and Therapeutics Committee, where the committee is responsible for drug selection, monitoring expired medications, compiling and distributing the hospital formulary, and providing appropriate therapy recommendations. The second theme is collaboration implementation, which is carried out through regular meetings, patient education, confirmation of drug availability and usage instructions, as well as coordination among healthcare professionals. The third theme is efforts to enhance collaboration, which include formulary updates, evaluation of drug needs, education for patients and medical personnel, and strengthening of standard operating procedures (SOPs) and interprofessional communication. The fourth theme is collaboration barriers, which include limitations in human resources, delayed communication, suboptimal evaluation of pharmaceutical personnel, and collaboration that is not yet fully integrated. Conclusion: The partnership between doctors and pharmacists at Hospital X in Magelang City in providing care for diabetes mellitus patients is in place but requires further optimization. To strengthen collaboration, the hospital can implement a structured interprofessional framework, including formal communication channels, cross-professional training, supportive internal policies, and active involvement of hospital management. These efforts are expected to enhance team effectiveness and improve the overall quality of patient care.